FI20100329A0 - Immunomodulatorinen adjuvanttihoito - Google Patents
Immunomodulatorinen adjuvanttihoitoInfo
- Publication number
- FI20100329A0 FI20100329A0 FI20100329A FI20100329A FI20100329A0 FI 20100329 A0 FI20100329 A0 FI 20100329A0 FI 20100329 A FI20100329 A FI 20100329A FI 20100329 A FI20100329 A FI 20100329A FI 20100329 A0 FI20100329 A0 FI 20100329A0
- Authority
- FI
- Finland
- Prior art keywords
- adjuvant therapy
- immunomodulatory adjuvant
- immunomodulatory
- alitretinoin
- employing
- Prior art date
Links
- 238000009098 adjuvant therapy Methods 0.000 title 1
- 230000002519 immonomodulatory effect Effects 0.000 title 1
- SHGAZHPCJJPHSC-ZVCIMWCZSA-N 9-cis-retinoic acid Chemical compound OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-ZVCIMWCZSA-N 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 229960001445 alitretinoin Drugs 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10045—Special targeting system for viral vectors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20100329A FI20100329A0 (fi) | 2010-09-24 | 2010-09-24 | Immunomodulatorinen adjuvanttihoito |
| PCT/FI2011/050820 WO2012038605A1 (en) | 2010-09-24 | 2011-09-23 | Viral therapy enhancing adjuvant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20100329A FI20100329A0 (fi) | 2010-09-24 | 2010-09-24 | Immunomodulatorinen adjuvanttihoito |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI20100329A0 true FI20100329A0 (fi) | 2010-09-24 |
Family
ID=42829651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20100329A FI20100329A0 (fi) | 2010-09-24 | 2010-09-24 | Immunomodulatorinen adjuvanttihoito |
Country Status (2)
| Country | Link |
|---|---|
| FI (1) | FI20100329A0 (fi) |
| WO (1) | WO2012038605A1 (fi) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5801029A (en) | 1993-02-16 | 1998-09-01 | Onyx Pharmaceuticals, Inc. | Cytopathic viruses for therapy and prophylaxis of neoplasia |
| AU2007215328A1 (en) * | 2006-02-13 | 2007-08-23 | Oncolytics Biotech Inc. | Use of local immune suppression to enhance oncolytic viral therapy |
-
2010
- 2010-09-24 FI FI20100329A patent/FI20100329A0/fi not_active Application Discontinuation
-
2011
- 2011-09-23 WO PCT/FI2011/050820 patent/WO2012038605A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012038605A1 (en) | 2012-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY34780A (es) | Vectores virales para el tratamiento de distrofia retiniana | |
| EA201291154A1 (ru) | Выбор дозы синтетических наноносителей с адъювантами | |
| UY34456A (es) | Anticuerpos anti-il-36r | |
| DK3403995T3 (da) | Jernhexacyanider med høj opløselighed | |
| IN2014CN02639A (fi) | ||
| BR112014033077A2 (pt) | combinação de vacina. | |
| UY34582A (es) | Anticuerpos anti-cxcr3 | |
| BR112013021779A2 (pt) | vacina de glicolipopeptídeo baseada em muc1 com adjuvante. | |
| UY34074A (es) | Composición oftálmica de olopatadina altamente concentrada | |
| CY1118539T1 (el) | Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο | |
| BR112014005756A2 (pt) | vacina | |
| CR20150084A (es) | 2-oxo-2,3-dihidro-indoles | |
| FR2988733B1 (fr) | Microorganisme recombinant | |
| CL2011002403S1 (es) | Luminaria solar. | |
| FI20110109A0 (sv) | Cykliskt PSD pressningsförfarande | |
| UY34286A (es) | Diagnóstico de vacuna mejorado | |
| MX335957B (es) | Absorbente de impacto ceramico a prueba de fuego. | |
| TR201007106A1 (tr) | Sefpodoksim proksetil formülasyonları. | |
| TR201009168A2 (tr) | Suda dağılan sefpodoksim proksetil formülasyonları. | |
| UY34501A (es) | ?procedimiento de purificación de factor viii?. | |
| IN2012DE02272A (fi) | ||
| FR2981207B1 (fr) | Source multi-faisceaux | |
| FI20100329A0 (fi) | Immunomodulatorinen adjuvanttihoito | |
| GB201120634D0 (en) | Adjuvant polypeptide | |
| IT1401158B1 (it) | Piano cottura |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |